RFC2 and astrocytoma (excluding glioblastoma): Based on WHO grade and pathological classification, a distinctively elevated expression of RFC2 was observed in LGG patients with WHO III grade (P < 0.001) and astrocytoma (P = 0.025 and P = 0.00067 respectively) (Fig. 3C,D).